BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kean R, Ramage G. Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris. mSphere 2019;4:e00458-19. [PMID: 31366705 DOI: 10.1128/mSphere.00458-19] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Nagy F, Vitális E, Jakab Á, Borman AM, Forgács L, Tóth Z, Majoros L, Kovács R. In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris. Front Microbiol 2020;11:957. [PMID: 32508780 DOI: 10.3389/fmicb.2020.00957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
2 Wu Y, Hu S, Wu C, Gu F, Yang Y. Probiotics: Potential Novel Therapeutics Against Fungal Infections. Front Cell Infect Microbiol 2022;11:793419. [DOI: 10.3389/fcimb.2021.793419] [Reference Citation Analysis]
3 Dekkerová J, Černáková L, Kendra S, Borghi E, Ottaviano E, Willinger B, Bujdáková H. Farnesol Boosts the Antifungal Effect of Fluconazole and Modulates Resistance in Candida auris through Regulation of the CDR1 and ERG11 Genes. J Fungi (Basel) 2022;8:783. [PMID: 35893151 DOI: 10.3390/jof8080783] [Reference Citation Analysis]
4 Ahmad S, Alfouzan W. Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities. Microorganisms 2021;9:807. [PMID: 33920482 DOI: 10.3390/microorganisms9040807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Di Luca M, Koliszak A, Karbysheva S, Chowdhary A, Meis JF, Trampuz A. Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry. J Fungi (Basel) 2019;5:E103. [PMID: 31698721 DOI: 10.3390/jof5040103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gupta A, Briffa SM, Swingler S, Gibson H, Kannappan V, Adamus G, Kowalczuk M, Martin C, Radecka I. Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications. Biomacromolecules 2020;21:1802-11. [PMID: 31967794 DOI: 10.1021/acs.biomac.9b01724] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 25.0] [Reference Citation Analysis]
7 Marena GD, Ramos MADS, Carvalho GC, de Lima LC, Nascimento ALCSD, Sábio RM, Rodero CF, Spósito L, Bauab TM, Chorilli M. Development and characterization of an amphotericin B - loaded nanoemulsion applied to Candida auris biofilms control. Journal of Drug Delivery Science and Technology 2022;74:103566. [DOI: 10.1016/j.jddst.2022.103566] [Reference Citation Analysis]
8 Butcher MC, Brown JL, Hansom D, Wilson-Van Os R, Delury C, Laycock PA, Ramage G. Antifungal loaded calcium sulfate beads as a potential therapeutic in combating Candida auris. Antimicrob Agents Chemother 2021;:AAC0171321. [PMID: 34694875 DOI: 10.1128/AAC.01713-21] [Reference Citation Analysis]
9 Maphanga TG, Naicker SD, Kwenda S, Muñoz JF, van Schalkwyk E, Wadula J, Nana T, Ismail A, Coetzee J, Govind C, Mtshali PS, Mpembe RS, Govender NP; for GERMS-SA. In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa. Antimicrob Agents Chemother 2021;65:e0051721. [PMID: 34228535 DOI: 10.1128/AAC.00517-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Tan X, Baugh K, Bulman ZP, Wenzler E. Review of the Current Management of Urinary Tract Infections due to Fluconazole-Resistant and Non-Albicans Candida Species. Curr Fungal Infect Rep 2020;14:268-78. [DOI: 10.1007/s12281-020-00388-1] [Reference Citation Analysis]
11 Carolus H, Pierson S, Lagrou K, Van Dijck P. Amphotericin B and Other Polyenes-Discovery, Clinical Use, Mode of Action and Drug Resistance. J Fungi (Basel) 2020;6:E321. [PMID: 33261213 DOI: 10.3390/jof6040321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Rosario-Colon J, Eberle K, Adams A, Courville E, Xin H. Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection. Int J Mol Sci 2021;22:6162. [PMID: 34200478 DOI: 10.3390/ijms22116162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Frías-De-León MG, Hernández-Castro R, Vite-Garín T, Arenas R, Bonifaz A, Castañón-Olivares L, Acosta-Altamirano G, Martínez-Herrera E. Antifungal Resistance in Candida auris: Molecular Determinants. Antibiotics (Basel) 2020;9:E568. [PMID: 32887362 DOI: 10.3390/antibiotics9090568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zamith-Miranda D, Heyman HM, Couvillion SP, Cordero RJB, Rodrigues ML, Nimrichter L, Casadevall A, Amatuzzi RF, Alves LR, Nakayasu ES, Nosanchuk JD. Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris. mSystems 2021;6:e0082221. [PMID: 34427507 DOI: 10.1128/mSystems.00822-21] [Reference Citation Analysis]
15 Wall G, Herrera N, Lopez-Ribot JL. Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box. J Fungi (Basel) 2019;5:E92. [PMID: 31581540 DOI: 10.3390/jof5040092] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
16 Willaert RG, Kayacan Y, Devreese B. The Flo Adhesin Family. Pathogens 2021;10:1397. [PMID: 34832553 DOI: 10.3390/pathogens10111397] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pezzotti G, Kobara M, Asai T, Nakaya T, Miyamoto N, Adachi T, Yamamoto T, Kanamura N, Ohgitani E, Marin E, Zhu W, Nishimura I, Mazda O, Nakata T, Makimura K. Raman Imaging of Pathogenic Candida auris: Visualization of Structural Characteristics and Machine-Learning Identification. Front Microbiol 2021;12:769597. [PMID: 34867902 DOI: 10.3389/fmicb.2021.769597] [Reference Citation Analysis]
18 Al Maani A, Paul H, Al-Rashdi A, Wahaibi AA, Al-Jardani A, Al Abri AMA, AlBalushi MAH, Al-Abri S, Al Reesi M, Al Maqbali A, Al Kasaby NM, de Groot T, Meis JF, Al-Hatmi AMS. Ongoing Challenges with Healthcare-Associated Candida auris Outbreaks in Oman. J Fungi (Basel) 2019;5:E101. [PMID: 31652825 DOI: 10.3390/jof5040101] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
19 Pezzotti G, Kobara M, Nakaya T, Imamura H, Asai T, Miyamoto N, Adachi T, Yamamoto T, Kanamura N, Ohgitani E, Marin E, Zhu W, Nishimura I, Mazda O, Nakata T, Makimura K. Raman Study of Pathogenic Candida auris: Imaging Metabolic Machineries in Reaction to Antifungal Drugs. Front Microbiol 2022;13:896359. [DOI: 10.3389/fmicb.2022.896359] [Reference Citation Analysis]
20 Kumar M, Singh A, Kumari S, Kumar P, Wasi M, Mondal AK, Rudramurthy SM, Chakrabarti A, Gaur NA, Gow NAR, Prasad R. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158815. [PMID: 32942047 DOI: 10.1016/j.bbalip.2020.158815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hao W, Wang Y, Xi Y, Yang Z, Zhang H, Ge X. Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris. J Infect Chemother 2022;28:29-34. [PMID: 34674944 DOI: 10.1016/j.jiac.2021.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Brown JL, Delaney C, Short B, Butcher MC, McKloud E, Williams C, Kean R, Ramage G. Candida auris Phenotypic Heterogeneity Determines Pathogenicity In Vitro. mSphere 2020;5:e00371-20. [PMID: 32581078 DOI: 10.1128/mSphere.00371-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
23 Chybowska AD, Childers DS, Farrer RA. Nine Things Genomics Can Tell Us About Candida auris. Front Genet 2020;11:351. [PMID: 32351544 DOI: 10.3389/fgene.2020.00351] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
24 Edouarzin E, Horn C, Paudyal A, Zhang C, Lu J, Tong Z, Giaever G, Nislow C, Veerapandian R, Hua DH, Vediyappan G. Broad-spectrum antifungal activities and mechanism of drimane sesquiterpenoids. Microb Cell 2020;7:146-59. [PMID: 32548177 DOI: 10.15698/mic2020.06.719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhou W, Li X, Lin Y, Yan W, Jiang S, Huang X, Yang X, Qiao D, Li N. A Comparative Transcriptome Between Anti-drug Sensitive and Resistant Candida auris in China. Front Microbiol 2021;12:708009. [PMID: 34354695 DOI: 10.3389/fmicb.2021.708009] [Reference Citation Analysis]
26 de Alteriis E, Maione A, Falanga A, Bellavita R, Galdiero S, Albarano L, Salvatore MM, Galdiero E, Guida M. Activity of Free and Liposome-Encapsulated Essential Oil from Lavandula angustifolia against Persister-Derived Biofilm of Candida auris. Antibiotics (Basel) 2021;11:26. [PMID: 35052903 DOI: 10.3390/antibiotics11010026] [Reference Citation Analysis]
27 Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. J Med Microbiol 2021;70. [PMID: 33599604 DOI: 10.1099/jmm.0.001318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Peyclit L, Yousfi H, Rolain JM, Bittar F. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi. Pharmaceuticals (Basel) 2021;14:488. [PMID: 34065420 DOI: 10.3390/ph14050488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Arias LS, Butcher MC, Short B, McKloud E, Delaney C, Kean R, Monteiro DR, Williams C, Ramage G, Brown JL. Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model. Antimicrob Agents Chemother 2020;64:e00476-20. [PMID: 32482674 DOI: 10.1128/AAC.00476-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
30 Sales G, Medeiros S, Soares I, Sampaio T, Bandeira M, Nogueira N, Queiroz M. Antifungal and Modulatory Activity of Lemon Balm (Lippia alba (MILL.) N. E. BROWN) Essential Oil. Sci Pharm 2022;90:31. [DOI: 10.3390/scipharm90020031] [Reference Citation Analysis]
31 Bravo Ruiz G, Ross ZK, Gow NAR, Lorenz A. Pseudohyphal Growth of the Emerging Pathogen Candida auris Is Triggered by Genotoxic Stress through the S Phase Checkpoint. mSphere 2020;5:e00151-20. [PMID: 32161147 DOI: 10.1128/mSphere.00151-20] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
32 Chen YC, Yang Y, Zhang C, Chen HY, Chen F, Wang KJ. A Novel Antimicrobial Peptide Sparamosin26-54 From the Mud Crab Scylla paramamosain Showing Potent Antifungal Activity Against Cryptococcus neoformans. Front Microbiol 2021;12:746006. [PMID: 34690992 DOI: 10.3389/fmicb.2021.746006] [Reference Citation Analysis]
33 Garcia-Bustos V, Cabanero-Navalon MD, Ruiz-Saurí A, Ruiz-Gaitán AC, Salavert M, Tormo MÁ, Pemán J. What Do We Know about Candida auris? State of the Art, Knowledge Gaps, and Future Directions. Microorganisms 2021;9:2177. [PMID: 34683498 DOI: 10.3390/microorganisms9102177] [Reference Citation Analysis]
34 Shahi G, Kumar M, Kumari S, Rudramurthy SM, Chakrabarti A, Gaur NA, Singh A, Prasad R. A detailed lipidomic study of human pathogenic fungi Candida auris. FEMS Yeast Res 2020;20:foaa045. [PMID: 32756963 DOI: 10.1093/femsyr/foaa045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]